150
Participants
Start Date
November 23, 2022
Primary Completion Date
December 31, 2024
Study Completion Date
July 30, 2025
GQ1005
an antibody drug conjugate
RECRUITING
Chinese PLA general hospital, Beijing
RECRUITING
Shengjing hospital of China medical universty, Shenyang
RECRUITING
The First Affiliated Hospital of Haerbin Medical University, Haerbin
RECRUITING
Fudan university Shanghai Cancer Center, Shanghai
RECRUITING
Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing
RECRUITING
Shandong Cancer Hospital, Jinan
RECRUITING
Yantai Yuhuangding Hospital, Yantai
RECRUITING
Linyi Cancer Hospital, Linyi
RECRUITING
Tianjin medical university cancer institute & hospital, Tianjin
RECRUITING
Sir Run Run Shaw Hospital (SRRSH), affiliated with the Zhejiang University School of Medicine, Hangzhou
RECRUITING
Fujian Cancer Hospital, Fuzhou
RECRUITING
Fujian Cancer Hospital, Fuzhou
RECRUITING
The First Affiliated Hospital of Chongqing Medical University, Chongqing
RECRUITING
Henan Cancer Hospital, Zhengzhou
RECRUITING
The First Affiliated Hospital of Zhengzhou University, Zhengzhou
RECRUITING
The First Affiliated Hospital of Xinxiang Medical University, Xinxiang
RECRUITING
Sichuan Cancer Hospital, Chengdu
RECRUITING
Suining Central Hospital, Suining
RECRUITING
The First Affiliated Hospital of Xi'an University, Xi'an
RECRUITING
Shanghai Pulmonary Hospital, Shanghai
GeneQuantum Healthcare (Suzhou) Co., Ltd.
INDUSTRY